Christine Delaisi

Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)

Antonio Ugolini, Mireille Kenigsberg, Alexey Rak et al. · Journal of Medicinal Chemistry · 2016 · 29 citations · Full text

Drug Target, Pharmacotherapy, Pharmaceutical Chemistry +18

The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in <i>MET</i> -Amplified Cancer

Coumaran Égile, Mireille Kenigsberg, Christine Delaisi et al. · Molecular Cancer Therapeutics · 2014 · 28 citations · Full text

Structure−Activity Relationships of a New Family of Steroidal Aromatase Inhibitors. 1. Synthesis and Evaluation of a Series of Analogs Related to 19-[(Methylthio)methyl]androstenedione (RU54115)

Dominique Lesuisse, Jean-François Gourvest, Ouafae Benslimane et al. · Journal of Medicinal Chemistry · 1996 · 18 citations · Full text

RU54115, a tight-binding aromatase inhibitor potentially useful for the treatment of breast cancer

Christine Delaisi, Bernard Doucet, Catherine Hartmann et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1992 · 10 citations

Tumor Biology, Tight-binding Aromatase Inhibitor, Breast Oncology +10